A systematic review of the label accuracy of cannabinoid-based products in regulated markets: is what's on the label what's in the product?

Karen OldfieldJohn RyanMarjan DoppenStacey M KungIrene BraithwaiteGiles Newton-Howes

Published in: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists (2020)

Label inaccuracies and contaminants are found across a spectrum of cannabinoid-based products. The review highlights the paucity and heterogeneity of research relating to cannabinoid-based products in light of changing global legislation. Further robust research is required to support ongoing pharmacovigilance and patient safety.

Keyphrases

patient safety
quality improvement
transcription factor
single cell
drinking water
drug induced